Natalie Johnson
Program: Cancer Biology
Current advisor: Carl DeSelm, MD, PhD
Undergraduate university: Oregon State University
Research summary
Tolerogenic dendritic cells (tolDCs) promote immune tolerance through antigen presentation, rather than immune activation. I aim to engineer tolDCs with chimeric antigen receptors (CARs) that direct them toward specific antigens in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, thereby inducing immune tolerance through the production antigen-specific regulatory T cells (Tregs).
Graduate publications